Overview
This pilot study addresses the urgent public health crisis of co-occurring opioid and alcohol use disorders (OUD-AUD), leading causes of mortality in the United States, by testing a scalable digital contingency management (CM) treatment among Medicaid beneficiaries. The study aims to evaluate the feasibility and acceptability of digital CM for OUD-AUD recovery, while also planning for broader implementation.
Eligibility
Inclusion Criteria:
- Participants must be enrolled in the Michigan Medicaid program
- Opioid agonist treatment (OAT): Participants must have initiated OAT with buprenorphine or methadone
- Participants must have an OAT prescription and Alcohol use disorder (AUD) based on self-report measure during screening
- Participants must have regular access to a working smartphone and internet connection.
- Participants must have a reliable mailing address to receive study supplies (e.g., salivary drug tests).
Exclusion Criteria:
- Primary Medicare Coverage: Individuals that are dual-eligible for Medicaid and Medicare and aged 65 or older, due to limited availability of Medicaid claims data for this group
- Individuals that cannot voluntarily provide informed consent themselves for any reason, including legal incompetency
- Individuals with substantial cognitive impairment that would interfere with study participation
- Individuals unable to read or understand English
- Individuals experiencing active suicidality or psychosis.
- Individuals with a planned admission to residential treatment or incarceration during the study period.